Modernize 1 — ASO

By Hello Thread on AppTrack Ninja.

Participant Study App

This app is intended for use by participants in the Modernize 1 study and requires an invitation and activation code from the study site to register. A Phase 2b, Randomized, Multicenter, Double-Blind, Dose-Finding, Active-Controlled Study of Siplizumab (TCD601) Compared to Rabbit Anti-Thymocyte Globulin in Renal Transplant Recipients Requiring Induction Therapy and Receiving Standard of Care Immunosuppression with Tacrolimus, Mycophenolic Acid and Corticosteroids (MODERNIZE 1). This study has been reviewed and approved by the appropriate regulatory body, e.g. Institutional Review Board (IRB) …

Categories: Medical, Health & Fitness

Keyword visibility, ranked search terms and daily position movement for Modernize 1.